GB9904935D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9904935D0
GB9904935D0 GBGB9904935.5A GB9904935A GB9904935D0 GB 9904935 D0 GB9904935 D0 GB 9904935D0 GB 9904935 A GB9904935 A GB 9904935A GB 9904935 D0 GB9904935 D0 GB 9904935D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9904935.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9904935.5A priority Critical patent/GB9904935D0/en
Publication of GB9904935D0 publication Critical patent/GB9904935D0/en
Priority to JP2000602074A priority patent/JP2002538119A/en
Priority to EP00907654A priority patent/EP1158981A1/en
Priority to AU29168/00A priority patent/AU2916800A/en
Priority to PCT/EP2000/001725 priority patent/WO2000051606A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
GBGB9904935.5A 1999-03-04 1999-03-04 Medicaments Ceased GB9904935D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9904935.5A GB9904935D0 (en) 1999-03-04 1999-03-04 Medicaments
JP2000602074A JP2002538119A (en) 1999-03-04 2000-03-02 Use of remifentanil for lowering blood pressure
EP00907654A EP1158981A1 (en) 1999-03-04 2000-03-02 Use of remifentanyl for reducing blood pressure
AU29168/00A AU2916800A (en) 1999-03-04 2000-03-02 Use of remifentanyl for reducing blood pressure
PCT/EP2000/001725 WO2000051606A1 (en) 1999-03-04 2000-03-02 Use of remifentanyl for reducing blood pressure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9904935.5A GB9904935D0 (en) 1999-03-04 1999-03-04 Medicaments

Publications (1)

Publication Number Publication Date
GB9904935D0 true GB9904935D0 (en) 1999-04-28

Family

ID=10848917

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9904935.5A Ceased GB9904935D0 (en) 1999-03-04 1999-03-04 Medicaments

Country Status (5)

Country Link
EP (1) EP1158981A1 (en)
JP (1) JP2002538119A (en)
AU (1) AU2916800A (en)
GB (1) GB9904935D0 (en)
WO (1) WO2000051606A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3192509B1 (en) * 2014-09-12 2021-03-31 Terumo Kabushiki Kaisha Remifentanil injection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466700A (en) * 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) * 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil

Also Published As

Publication number Publication date
JP2002538119A (en) 2002-11-12
WO2000051606A1 (en) 2000-09-08
AU2916800A (en) 2000-09-21
EP1158981A1 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
GB0009605D0 (en) Medicaments
HUP0203585A3 (en) Pharmaceutical combinations
EG23858A (en) Drug combination
GB0002312D0 (en) Medicaments
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
AU1645700A (en) Oenothein medicaments
GB9915231D0 (en) Pharmaceutical complex
GB0024362D0 (en) Medicaments
GB9930083D0 (en) Medicaments
GB9924990D0 (en) Medicaments
GB0015324D0 (en) Medicaments
GB9930082D0 (en) Medicaments
GB9929040D0 (en) Medicaments
GB9828620D0 (en) Medicaments
GB9904935D0 (en) Medicaments
GB9929039D0 (en) Medicaments
GB9901236D0 (en) Medicaments
GB9902251D0 (en) Medicaments
GB9923675D0 (en) Medicaments
GB9915471D0 (en) Medicaments
GB9910076D0 (en) Medicaments
GB9930106D0 (en) Medicaments
GB9910916D0 (en) Medicaments
GB9911499D0 (en) Medicament

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)